2024 Annual Meeting Presentation Material

Iperion Limited
Annual Meeting
27 September 2024

Agenda
•
Welcome and Introductions
•
Formalities
•
Presentation to Shareholders
•
Q&A Discussion
•
Resolutions

Formalities
•
Attendance of the virtual meeting has been left open for all
interested to be able to attend.
•
The meeting is recorded.
•
To ensure that voting is accounted for correctly, all votes will
be required to be submitted electronically. For shareholders
who have not voted yet via Link, but still wish to do so after
the meeting, please forward your completed voting form to
john.cilliers@outlook.co.nz by no later than 4pm today.
(contact John if you need a form)

Review of the year ended 31 March 2024
•
Increase in interest income as result of
higher bank interest rates
•
Outsource Plant expense is a fixed fee
of $400k p.a. 2024 includes
establishment cost.
•
Admin expenses higher in 2024 mainly
in audit fees, expenditure on oversight
of the manufacturing plant and product
marketing activities.
•
Impairment expense is on trademark
intangibles. Expected to be reversed
once the value of sales support the
intangibles valuation.
•
There were no changes in the number
of shares on issue
2023
$
2024
$
26,12141,396Interest income
0500,000
Outsource
Manufacturing Plant
306,197354,372Administrative expenses
09,283Impairment expense
280,107822,259Net loss
1,626,340804,081Net assets
1,593,924866,481Cash and Term deposits

Progress and current activities

Company name changed to Iperion Limited.

Kicked off marketing at Arabplast exhibition in Dubai (Dec’23). Since followed
by other presentations in Bangkok, Singapore, Malaysia

Pathoglaze
®
registered as a trademark in NZ/Australia/EU/China/Singapore.
(Underway in others in accordance with the Madrid protocol)

Certified as green technology product from GPM Global USA and further
awarded as the Green Project Malaysia GPM Sustainability Award
2023Certifications on Manufacturing Facility.

Numerous product trials underway with customers, ranging from Germany,
Japan, Taiwan etc on a range of possible application of the product (more
info in following slide)

Currently conserving cash until sales commence by some of the costs of the
outsourced manufacturing plant being supported with research grants.

Pathoglaze is a durable, high potency, anti-
microbial product capable of being
incorporated into raw materials for other
products at the point of manufacture.
For example it can be incorporated in plastics
masterbatch powders prior to product
moulding or it can be applied to existing
products as a thin film coating.

PATHOGLAZE®Hyperion is a high-potency zinc-basedantimicrobial additive.
Having a core shell- nanopillar morphological structure.
It can kill, reduce and prevent the growth of harmful microorganism (e.g.: bacteria,
virus, fungi, algae).
Having an antimicrobial activity up to 99.9 % (test method: ISO22196).
Can be seamlessly incorporated in a wide range of end-use products during
the manufacturing process without interfering with the actual manufacturing
setup.
HYPERIONAdditive
–greyish powder
Fine Powder (Additives)

UNIQUE MECHANISM
Does not rely on external
stimulus light energy to
generate ROS.
SAFETY
Safe to be used as additive in
food packaging polymers.
*Tested in compliance with
US FDA and EU regulation.
EFFICACY
99.9 % effective against
microorganisms, even
at low use levels.
STABILITY
It has thermal resistance
up to 410 °C and is
insoluble in water.
FLEXIBILITY
Seamless incorporation
into a wide range of
applications.
Key Features
Additives
PATHOGLAZE

PLASTICS AND POLYMERS
(Food-grade and non food-grade)
List of polymers compatible with PATHOGLAZE:
i. Commodity thermoplastics (i.e.: PE, PS)
ii. Engineering thermoplastics (i.e.: PC, ABS, PC/ABS,
PA)
iii. Thermosets (i.e.: epoxy)
iv. Synthetic rubber (i.e.: NBR and EPDM)
PAINTS AND COATINGS
By Applications
Area of Application
PATHOGLAZE®

Our PATHOGLAZE®additives are compatible with almost all plastics and
polymer materials (i.e.: trial for PP, PC and ABS).
With 0.5%of PATHOGLAZE loading = 99.9%of antimicrobial activity
(ISO22196)
Seamlessly compound in polymer using the existing process
Embedded within the polymer compound itself, delivering continuous
protection against microbes without affecting gloss or matte surfaces, color,
durability, and properties.
PP compound with 0.5% of
PATHOGLAZE
PASS
In-polymer Food Contact Test according to
-US FDA 21 CFR 177.1520
PASS
Migration Test according to Commission Regulation (EU)
-EU 10/2011 Article 3 of European Regulation
1935/2004*
Polymer compound

P o t e n t i a l
PATHOGLAZE
APPLICATION
Cutting boards, wall coverings, appliances,
toilet seats, flooring, mattresses
Housewares:
PVC blinds, car interiors, packaging, signs,
electronics, seating
Commercials:
yoga mats, footwear, duffle bags,
sports equipment
Fitness:
flooring, vinyl siding, windows, insulation,
piping, roofing membranes
Construction materials:
business supplies, medical devices, seating,
countertops, storage
Healthcare:

i. Prevents the growth of bacteria and fungi on the surface.
ii. Reduces bacteria in the surrounding area, and reduces the spread of infection.
iii. Prolongs food shelf life.
iv. Promotes product reusability and recyclability.
Packaging (primary & secondary)

Thin film is a layer of material with a thickness ranging from a
nanometer to micrometer on the surface of a substrate.
Harnessing the potential of zinc, PATHOGLAZE thin film is a
zinc-based thin-film coating.
PATHOGLAZE
®
thin film series is particularly targeted for
coating on non-porous surfaces i.e.; glass windows, solar
panels, touch-sensitive displays, etc. where transparency
coating is a key consideration.
Thin Film

Manufacturing Facility
Located in Malaysia
Received Green Project Certification for PATHOGLAZEProject
from GPM Global USA.
Received Malaysia GPM Sustainability Award 2023: Project of
the Year

Questions

Resolution 1
BDO is automatically reappointed at the annual meeting as the auditor of the Company
under section 207T of the Companies Act. This resolution authorises the Board to fix the
fees and expenses of the auditor.
Ordinary Resolution: That the Board is authorised to fix BDO Auckland’s fees and
expenses as the auditor of IPR.
Abstain
% of Issued
Capital
AgainstOpenFor
0
78.99%5004,000406,692,355
Votes
149Holders
0.00%0.00%100.00%
Percentage
Proxies:

Thank you